VF showed decreased clearance of food residue during the pharyngeal phase and retention and reflux during the esophageal phase. with IMNM. At age 90, she was admitted to our hospital for treatment and received immunotherapy including intravenous methylprednisolone, oral prednisolone, methotrexate and intravenous immunoglobulin therapy. A swallowing screening test immediately after AB05831 admission exposed coughing during water drinking, but this improved with thickened fluids. The patient continuing to experience choking during meals, prompting a videofluoroscopic swallowing study (VF). AB05831 VF showed decreased clearance of food residue during the pharyngeal phase and retention and reflux during the esophageal phase. Despite immunotherapy, the patient did not encounter any significant improvement in medical symptoms, including limb strength or dysphagia. This case statement shows dysphagia inside a seronegative IMNM patient, demonstrating food retention and reflux in the lower esophagus and decreased pharyngeal clearance on VF. This suggests potential esophageal clean muscle mass damage due to an autoimmune mechanism. Further study on dysphagia in IMNM, particularly in the seronegative type, is crucial to understand the pathogenesis and develop effective treatment strategies. Keywords:achalasia esophagus, dysphagia’, immune-mediated inflammatory myopathy, immune-mediated necrotizing myopathy, videofluoroscopic swallowing studies == Intro == Immune-mediated necrotizing myopathy (IMNM) is definitely a distinct subtype of idiopathic inflammatory myopathies (IIMs), characterized by prominent muscle mass AB05831 dietary fiber necrosis and minimal or absent perivascular inflammatory cells [1]. IMNM is definitely differentiated from additional IIMs by the presence of specific autoantibodies, including anti-signal acknowledgement particle (SRP) and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) antibodies [1,2]. AB05831 Currently, four pathogenic focuses on of SRP antibodies are acknowledged: SRP19, SRP54, SRP72 proteins, and 7SL RNA, while HMGCR antibodies are associated with statin use [2]. Additionally, seronegative IMNM is now acknowledged as a new subtype [1,2]. All organizations show related characteristics, typically showing as acute or subacute proximal muscle mass weakness having a symmetrical pattern, often accompanied by myalgia [2]. Individuals with anti-SRP positive IMNM encounter more severe muscle mass weakness than those with anti-HMGCR positive or seronegative IMNM, and are at improved risk for cardiac involvement, interstitial lung disease, and dysphagia [3,4]. Conversely, individuals with anti-HMGCR positive IMNM primarily show muscle mass weakness without extra-muscular involvement [3]. While seronegative IMNM remains less understood, AB05831 evidence suggests that individuals with this category may have an elevated risk Rabbit polyclonal to MICALL2 of malignancy compared to antibody-positive individuals [2,5]. Dysphagia is definitely relatively common in IMNM individuals, happening in 20-35% of individuals, including those with the seronegative type [6-8]. While several case reports of IMNM-associated dysphagia exist [7-11], you will find no detailed reports on dysphagia in antibody-negative IMNM, including videofluoroscopic swallowing study (VF) profiles. This statement explains a case of seronegative IMNM with dysphagia and details its VF findings. == Case demonstration == An 88-year-old Japanese female with a history of appendicitis, hypertension, and dyslipidemia developed right shoulder pain, followed by muscle mass weakness in the right shoulder. She experienced no family history of neuromuscular disorders. She went to a previous hospital, where biceps brachii tears were identified. At the age of 89, she developed muscle mass weakness in her lower limbs. Although she underwent right shoulder arthroplasty, the improvement in muscle mass weakness was limited. Over several months, she experienced progressive muscle mass weakness in the bilateral shoulder muscle tissue and lower limbs. One year after the onset of her initial symptoms, head ptosis and remaining rotator cuff tears were mentioned. Additionally, she started to encounter choking when consuming fluids. Due to suspected neuromuscular diseases, she went to our hospital. The neurological exam exposed no blepharoptosis, muscle mass weakness in the face, fasciculations or ataxia; however, the sternocleidomastoid, trapezius, neck flexors, and extensors, as well as the proximal.